Advertisement

Topics

Latest "Reducing Sedentary Time in Patients With Heart Failure" News Stories

11:05 EDT 26th March 2019 | BioPortfolio

Here are the most relevant search results for "Reducing Sedentary Time in Patients With Heart Failure" found in our extensive news archives from over 250 global news sources.

More Information about Reducing Sedentary Time in Patients With Heart Failure on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Reducing Sedentary Time in Patients With Heart Failure for you to read. Along with our medical data and news we also list Reducing Sedentary Time in Patients With Heart Failure Clinical Trials, which are updated daily. BioPortfolio also has a large database of Reducing Sedentary Time in Patients With Heart Failure Companies for you to search.

Showing "Reducing Sedentary Time Patients With Heart Failure" News Articles 1–25 of 32,000+

Tuesday 26th March 2019

Takeda Presents New Data at the Endocrine Society’s 2019 Annual Meeting about the Patient Burden and Long-Term Impact of Chronic Hypoparathyroidism

Impact on patient quality of life quantified including long-term renal and cardiovascular complications Final outcomes of 6 year study into continuous use of rhPTH(1-84) shows improvements in key measurements of mineral homeostasis Takeda Pharmaceutical Company Limited (


Growing evidence shows the numerous relationships that exist among metabolic, heart failure, arterial vascular and renal diseases. Considering and addressing their common mechanisms could help improve outcomes in patients with one disease diagnosis before

Growing evidence shows the numerous relationships that exist among metabolic, heart failure, arterial vascular and renal diseases. Considering and addressing their common mechanisms could help improve outcomes in patients with one disease diagnosis before co-morbidities emerge. pic.twitter.com/JbdjAgFDik

Leafly Announces European Medical Cannabis Conference Scheduled for September 21-22, 2019 in Berlin

For the first time, Leafly, the world's cannabis information resource, is bringing together international participants and exhibitors at a conference for medical professionals in Europe. At the end of September, doctors, pharmacists and researchers are expected to meet in Berlin to discuss the use of cannabinoids in the medical practice. On Septem...


BrightWater Medical secures FDA clearance for ConvertX biliary stent system

The medical device company said that the patients with severe duct blockages or gastric bypass or liver transplant patients may either undergo two separate one-hour interventional procedures for The post BrightWater Medical secures FDA clearance for ConvertX biliary stent system appeared first on Compelo Medical Devices - Latest industry news and analysis.

Ethicon to collect data on liver lesions ablated with NEUWAVE Microwave Ablation System

Ethicon made the announcement at the Society of Interventional Radiology (SIR 2019), which is being held in Austin, Texas. The multicenter, observational registry will follow about 1,500 patients The post Ethicon to collect data on liver lesions ablated with NEUWAVE Microwave Ablation System appeared first on Compelo Medical Devices - Latest industry news and analysis.

Spok Improves Care Team Communication at Vail Health

Community health system expands use of Spok Care Connect® across its medical centers and clinics Spok, Inc., a wholly owned subsidiary of Spok Holdings, Inc. (NASDAQ: SPOK) and a global leader in healthcare communications, announced that Vail Health has improved care team communication with

Eisai, Biogen move Alzheimer’s treatment into Phase III

Eisai and Biogen's BAN2401 is to be put into Phase III trial for patients with early Alzheimer's disease.

Rituximab found to extend progression-free survival in indolent lymphoma

New trial results have been published showing that a combination of Celgene's Revlimid and Roche's rituximab significantly extended progression-free survival in patients with relapsed or refractory indolent lymphoma, compared to rituximab with placebo.

McKesson ideaShare Unites Independent Pharmacy

Premier community pharmacy education and networking event hits Orlando in 2019 Registration is now open for McKesson ideaShare in Orlando from June 26–30, 2019. Pharmacists, pharmacy owners and pharmacy technicians have the chance to

UBCF to hold Pink Bag Event® at Barclays Center, Brooklyn, NY

Breast Health Education & Cancer Prevention Event Open to All HUNTINGTON STATION, N.Y. (PRWEB) March 26, 2019 United Breast Cancer Foundation (UBCF) is proud to announce their partnership with the Barclays Center in Brooklyn, NY. Through this partnership, UBCF will be hosting an Educational Outreach and Pink Bag Event® at the Barclays Center in Brooklyn, NY on Wednesday, April 3rd from 8...

Vivior’s System Cleared for CE Mark – Market Introduction This Year in Europe

Vivior has cleared their system as a Class I medical device and is planning the market introduction later this year in Switzerland and the European Union. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190326005594/en/ The Visual Behavior

Comparable Efficacy of Generic and Brand-Name Drugs for Chronic Conditions Shown in Study

Although generic versions of prescription medications can be a cheaper alternative for patients, many perceive generics as less effective and less safe than their brand-name counterparts.

It Hurts Me to Sit, Stand and Sleep; Tests to Diagnose Causes of Back Pain

Dr. Kaixuan Liu with Atlantic Spine Center with tips on top ways doctors figure out the cause of your aching back. WEST ORANGE, N.J. (PRWEB) March 26, 2019 Back pain is usually fleeting, with most cases lingering less than 4 to 6 weeks. But when back pain becomes chronic, tests to diagnose back pain and its causes may be your best path to relief, according to Kaixuan Liu, MD, PhD, founder and Med...

Fina Biosolutions’ Licensee Successfully Completes a Phase 3 Study and Enters World Health Organization (WHO) Registration for Pneumosil®

Serum Institute of India completes a Phase 3 clinical trial with chemistry developed by Fina Biosolutions Fina Biosolutions is pleased to announce that the Serum Institute of India Private Limited (SIIPL), has completed a Phase 3 study for Pneumosil® a 10-valent pneumococcal conjugate vaccine, in which the Serum Institute indicates all primary and sec...

Compulink Previews New User Interface for its Ophthalmology SMART EHR at AAPOS 2019

Compulink Healthcare Solutions, the creator of Advantage SMART Practice®, an all-in-one EHR and practice management solution powered by artificial intelligence (AI), will preview the new user interface for its

iKnowMed Named Top-Performing Electronic Health Record by Black Book Research for Eighth Consecutive Year

Strong ratings in key performance indicators enable iKnowMed to retain its #1 ranking iKnowMedSM, McKesson’s oncology practice electronic health record (

OncoLens Raises Seed Funding of $1.35 Million Led by BIP Capital and Atlanta Technology Angels

Platform enables a diverse and multispecialty cancer care team to seamlessly collaborate on treatment plans for individual patients. OncoLens, a technology company serving cancer care programs has successfully closed a $1.35 million seed round. BIP Capital and Atlanta Technology Angels (ATA) led the round. The company will deploy the capital toward its...

Medical Device Startup HeartHero Wins Innovation Challenge With Mission to Save Lives Via Personal Automated External Defibrillator (AED)

HeartHero, the medical device startup and creator of the ultra-portable, affordable, and user-friendly automated external defibrillator (AED) was recently awarded a win at the American College of Cardiology’s 68th annual conference, ACC.19. Co-hosted with

Joe Hall Joins AccessOne as Senior Vice President of Business Development

AccessOne, a leading provider of patient financing options designed to help patients manage their healthcare costs, today announced it has hired Joe Hall as its senior vice president of business development. Hall reports to the chief executive officer and is responsible for AccessOne’s business development strategy and

Collective Medical Appoints Jim Lacy as President and Chief Operating Officer

Lacy to apply his proven approach to strategy, policy and product to accelerate rapid growth toward connecting the healthcare system at scale Collective Medical, delivering the nation’s largest and most effective network for care collaboration, today announced the appointment of Jim Lacy as president and chief operating officer. This press rele...

Partners in Primary Care to Expand its U.S. Footprint with 10 New Centers

New senior-focused primary care centers will open this year in South Carolina and Texas Partners in Primary Care will bring its innovative, senior-focused primary care model to 10 additional locations in 2019. The company will open five medical centers in South Carolina, and five in Texas. Partners in Primary Care, a subsidiary of

Say Good Bye to Meniere’s Disease—Here’s How to Make Your World Stop Spinning

GRAND RAPIDS, Mich. (PRWEB) March 25, 2019 Please join twenty thousand Meniere’s patients that have been helped since the Journal of Upper Cervical Chiropractic Research published "Health Outcomes Following Cervical Specific Protocol with Meniere's Followed Over Six Years," cele...

Japan’s Ministry of Health, Labour and Welfare Approves Gilead’s Biktarvy® (Bictegravir, Emtricitabine and Tenofovir Alafenamide) for Treatment of HIV-1 Infection

– In Clinical Trials, Biktarvy Demonstrated High Efficacy, Few Interactions with Other Drugs and a High Barrier to Resistance Through 48 Weeks – Gilead Sciences, Inc. (NASDAQ:GILD) announced today that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Biktarvy® (bictegravir 50mg/emtricitabine 200mg/tenofovir alafenamide 25mg, ...

Scientists Were Ready To Declare Measles All But Dead. Now, It’s Come Back With A Vengeance.

Experts are absolutely frustrated that a virus that was near extinction is gaining so much ground recently. The measles vaccine is enough to do the job to kill it completely for future generations, they believe, but the resistance movement is thwarting that progress. In other public health news: autism, asthma, sonic attacks, DNA and fast food, and heart attacks.

Leading Medical Groups Issue Call To Arms Against Soda Industry Dubbing Sugary Drinks As ‘Low-Hanging Fruit’ In Obesity Wars

The American Academy of Pediatrics and the American Heart Association said lawmakers should utilize taxes and warning labels to cut down on the prevalence of sugary drinks in U.S. culture.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks